Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group

The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengruppe Hämatologie und Onkologie (OSHO), initiated in 2007 a double randomized trial to investigate efficacy and safety of rituximab maintenance versus observation in remission after randomly assigned in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirt, Carsten, Hoster, Eva, Unterhalt, Michael, Hänel, Mathias, Prange-Krex, Gabriele, Forstpointner, Roswitha, Florschütz, Axel, Graeven, Ullrich, Frickhofen, Norbert, Wulf, Gerald, Lengfelder, Eva, Lerchenmüller, Christian, Schlag, Rudolf, Dierlamm, Judith, Fischer von Weikersthal, Ludwig, Ahmed, Asima, Harich, Hanns-Detlev, Rosenwald, Andreas, Klapper, Wolfram, Dreyling, Martin, Hiddemann, Wolfgang, Herold, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221804/
https://www.ncbi.nlm.nih.gov/pubmed/34179697
http://dx.doi.org/10.1097/HS9.0000000000000600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221804/
https://www.ncbi.nlm.nih.gov/pubmed/34179697
http://dx.doi.org/10.1097/HS9.0000000000000600

Ejemplares similares